| James Carpenter, MD | |
|
5620 W Thunderbird Rd, C1, Glendale, AZ 85306-4636 | |
| (602) 938-6960 | |
| (602) 938-6069 |
| Full Name | James Carpenter |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 5620 W Thunderbird Rd, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073513131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 26095 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Arizona Llc | 3173872835 | 198 |
News Archive
Health care providers and hospitals are being offered up to $27 billion in federal financial incentives to use electronic health records (EHRs) in ways that demonstrably improve the quality of care. The incentives are based, in part, on the ability to electronically report clinical quality measures.
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neogenix Oncology, Inc. has announced that the company's novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover's 2011 Top 10 Projects to Watch.
› Verified 3 days ago
| Entity Name | Arizona Primary Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033523949 PECOS PAC ID: 8820316334 Enrollment ID: O20150414000437 |
News Archive
Health care providers and hospitals are being offered up to $27 billion in federal financial incentives to use electronic health records (EHRs) in ways that demonstrably improve the quality of care. The incentives are based, in part, on the ability to electronically report clinical quality measures.
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neogenix Oncology, Inc. has announced that the company's novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover's 2011 Top 10 Projects to Watch.
› Verified 3 days ago
| Entity Name | Summit Medical Group Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053810622 PECOS PAC ID: 3173872835 Enrollment ID: O20180814003015 |
News Archive
Health care providers and hospitals are being offered up to $27 billion in federal financial incentives to use electronic health records (EHRs) in ways that demonstrably improve the quality of care. The incentives are based, in part, on the ability to electronically report clinical quality measures.
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neogenix Oncology, Inc. has announced that the company's novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover's 2011 Top 10 Projects to Watch.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Carpenter, MD 5620 W Thunderbird Rd, F1, Glendale, AZ 85306-4636 Ph: (602) 938-6960 | James Carpenter, MD 5620 W Thunderbird Rd, C1, Glendale, AZ 85306-4636 Ph: (602) 938-6960 |
News Archive
Health care providers and hospitals are being offered up to $27 billion in federal financial incentives to use electronic health records (EHRs) in ways that demonstrably improve the quality of care. The incentives are based, in part, on the ability to electronically report clinical quality measures.
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neogenix Oncology, Inc. has announced that the company's novel antibody NEO-101, which targets pancreatic and colorectal cancer cells, has been selected as one of Windhover's 2011 Top 10 Projects to Watch.
› Verified 3 days ago
Dr. Stephanie D Martinez Hawthorne, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7701 W Aspera Blvd, Glendale, AZ 85308 Phone: 623-248-2109 Fax: 623-707-4893 | |
Dr. Sanjay B Kulkarni, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
Arya John Nikamal, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5555 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-865-5555 | |
David Warfield, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5601 W Eugie Ave Ste 203, Glendale, AZ 85304 Phone: 602-633-3833 Fax: 602-633-3834 | |
Anne Margaret Floyd, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5620 W Thunderbird Rd Ste H3, Glendale, AZ 85306 Phone: 480-994-5012 | |
Dr. Karen Brenda Alonso, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
Dr. Abrar U Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 W Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2631 |